Peer Review History
| Original SubmissionOctober 21, 2021 |
|---|
|
PONE-D-21-33729Frailty does not cause all frail symptoms: United States Health and Retirement StudyPLOS ONE Dear Dr. Chao, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. The two reviewers made substantial comment on the paper, the first being more food for thought than substantial request for revision, but worthy of consideration and comment Please submit your revised manuscript by Jun 24 2022 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Adrian Stuart Wagg, MD Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. Thank you for stating the following in the Competing Interests section: YSC is employed by the Canadian Agency for Drugs and Technologies in Health. YSC conducted this study as an independent researcher out of academic curiosity without any material support. No external funding was received for this study. This study is not associated with any patents, products in development or marketed products. Please confirm that this does not alter your adherence to all PLOS ONE policies on sharing data and materials, by including the following statement: "This does not alter our adherence to PLOS ONE policies on sharing data and materials.” (as detailed online in our guide for authors http://journals.plos.org/plosone/s/competing-interests). If there are restrictions on sharing of data and/or materials, please state these. Please note that we cannot proceed with consideration of your article until this information has been declared. Please include your updated Competing Interests statement in your cover letter; we will change the online submission form on your behalf. 3. Your ethics statement should only appear in the Methods section of your manuscript. If your ethics statement is written in any section besides the Methods, please move it to the Methods section and delete it from any other section. Please ensure that your ethics statement is included in your manuscript, as the ethics statement entered into the online submission form will not be published alongside your manuscript. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: Yes ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: I Don't Know Reviewer #2: Yes ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: It is always to see research done to appreciate and explore the concept of fitness of frailty and to explore which aspects of this phenomenon can potentially be intervened on. However; I am not sure if I agree with the premise of this paper, which seems to assume that each variable that makes up a model of measurement of physiological reserves or “frailty”, ought to correlate with the entire model or measuring tool that has been described. I am also not entirely surprised to see that there are some variables, when assessed individually, that do not correlate with the models or measures of frailty. Comments: 1. “Frailty is a geriatric syndrome….”. This is not true. Frailty is a concept/phenomenon that has been shown to exist across the numeric age spectrum. Although it is increasingly prevalent with increasing numeric age, it is not an exclusive phenomenon in those who are of a particular older numeric age. 2. Frailty is a term used to describe the amount or degree of physiological reserves an individual has. Such that, the more amount of physiological reserves an individual has, the more resilient he or she is in the way of any “stressors” (e.g. disease, interventional treatments) that they face. It takes less degree of stressor to destabilize an individual’s homeostasis, if they have less reserves or if they are frail. Fit patients are less likely to decompensate medically and functionally in the way of stressors, unlike frail individual, because they more physiological reserves. Fitness and frailty are used to describe the entire set of reserves in an individual. It is akin to trying to determine the degree of fibrotic tissue or liver reserves or cirrhosis in an individual with liver disease. However, “frailty” is more complex, because it is an attempt describe and measure reserves in an entire individual 3.regarding the line: “ the causal relationships between frailty and frailty symptoms can be confirmed based on previously published criteria.” I am not convinced that these criteria or any other attempts to measure or describe the concept of physiological reserves or frailty, has demonstrated any casual relationship between frailty or any “frailty symptoms as is suggested by this paper. 4. Instead, the ways in which various measures or tools that are used to assess frailty, use a multitude of variables that include: a. Contributing factors (e.g. various disease processes, comorbidities) b. Phenotypic markers (e.g. sarcopenia, and measures of sarcopenia – e.g. grip strength) c. Sequalae of being fit or frail (e.g. degree or function or dysfunction, number or falls, low mood) To what extent an individual’s reserves are diminished cannot accurately be determined by any single variable captured by a tool. Simply having the presence of heart failure, does not automatically reflect that someone is frail. However, in someone with long standing severe heart failure, it is conceivable that they may become deconditioned after some time (partially reflected by sarcopenia, and it’s measures) , and that after some time, that degree of sarcopenia or deconditioning may lead to loss of strength and decline in functioning. It is conceivable that after some time, that they may have low mood or depression as a result of their inability to function to their previous extent. At the same time, it is also conceivable that a disorder such as a depression may not only be a resulting factor of being frail, but it may also be a contributing factor. For example, someone with a primary psychiatric diagnosis of major depressive disorder, with otherwise manageable heart failure, may not adhere to their medications while depressed. They may also not be physically active. This may worsen their heart failure. This may in turn lead to them to becoming frail, if their issues are not managed. 5. Single variables may also be mild, early, or transient (potentially cured) in nature, such that their existence at a particular cross-section (when the frailty measure is use) may not be enough to cause a degree of diminished physiological reserves to be frail. This is conceivable for the variables assessed in this study, For example, malignant disease or history of, tiredness all of the time, memory change and headache, which did not correlate with frailty status. Some variables, when they become severe, may draw out other variables that are part of a model or measurement tool for frailty/reserves. In that regard, a single variable may not capture the extent of diminished reserves, as perhaps a tool or measure that encompasses multiple variables does or a tool that captures the enduring effects the things that can contribute to frailty do (e.g. permanent loss of function). As such, the interaction of the variables also plays an important role. 6. Other specific aspects of the paper a. It would be easier to label the measure or models as they are commonly described e.g. Rockwood’s “frailty index” or “Fried model” or “Phenotypic model”. Otherwise, it does get confusing to keep track of which is what with newer ways of describing them. b. The paper by Strawbridge et al. that was published in 1998 lays out variables or items that are more commonly reflected in those who are frail versus non frail. I am not sure if it was intended to be a “model” or a measure of reserves, in the way that the other two were. Also, has this approach been validated in various settings as has the other two models? c. The use of the term “frailty symptoms”, in my opinion, over simplifies what the variables in the various measures of physiological reserves/fitness-frailty are attempting to capture. (see point 4 above). d. “it has been suggested that cognitive impairment plays an important role for frailty diagnosis and mortality among frail patients”. Cognitive impairment, if it does not go beyond erosion of domain deficits, that is if there is no resulting functional deficits (which would then be dementia) may reflect some degree of diminishment physiological reserves, but it may not reach the “threshold” for reflecting frailty in the way moderate to severe might. At the same time, there are individuals who have enough of their physiological reserves eroded (due to other processes or variables) that they have become “frail”, but who still have their cognitive abilities intact. Overall: Areas of improvements or cons of the article: There is an over simplification of the concept of frailty reflected by terms such as: “diagnose frailty”, “symptoms of frailty” and “causality” . I am also not entirely convinced on the premise of the article which seems to be that the individual variables that make up the various tools ought to be reflective the extent of physiological reserves or frailty and be as reflective of the ability of the various measuring models or tools (that capture a variety of variables). Items/variables used in the various models or measuring tools of assessing physiological reserves/fitness-frailty do not necessarily reflect "symptoms of frailty"(see point 4). In addition, variables that reflect degree of physiological reserves (either as contributing factors, phenotypic manifestations or resulting factors) can either be mild or severe or transient, and can draw in other variables given the nature of the variable. As such, a more nuanced approach is required to assess which variables that reflect frailty, can be "targeted" to help management strategies. For example: in this article, malignancy or having a history of malignancy did not correlate with being frail. Once could conceive that if an early malignant process were to progress towards metastasis, that perhaps at some point, a patient would be more “frail” towards the end of the process than at the start. It would be worthwhile trying to stop the malignancy nonetheless, as it would be important to try to stop or modify other contributing factors to frailty, before someone has already become frail. Positives: Exploring models or measures of “reserves” to determine their strengths and weakness. There is also, I believe, an unintended, but important purpose that can be derived from this article, even though it has not been stated: in an effort to choose a measuring tool or model for “physiological reserves” or frailty, there may be value in having a tool that is practical to use in particular settings. That practically may be achieved with a tool that perhaps has the least amount of variables, while still being effective. Reviewer #2: Please refer to the attached document for my comments. Overall, I think this an interesting and valuable study, which has highlighted an important issue. All my comments are all focused on spelling and grammar only. ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: No [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.
|
| Revision 1 |
|
Frailty does not cause all frail symptoms: United States Health and Retirement Study PONE-D-21-33729R1 Dear Dr. Chen, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, George Vousden Staff Editor PLOS ONE Additional Editor Comments (optional): Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #1: All comments have been addressed Reviewer #2: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: I Don't Know Reviewer #2: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: (No Response) Reviewer #2: I think this is an interesting study which has highlighted a controversial issue that should be looked at. ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: Yes: Naheed A. Rajabali MD MSc FRCPC Reviewer #2: No ********** |
| Formally Accepted |
|
PONE-D-21-33729R1 Frailty does not cause all frail symptoms: United States Health and Retirement Study Dear Dr. Chen: I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department. If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org. If we can help with anything else, please email us at plosone@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. George Vousden Staff Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .